These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463 [TBL] [Abstract][Full Text] [Related]
5. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance. Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693 [TBL] [Abstract][Full Text] [Related]
6. [Hypertension and insulin resistance]. Voiculescu A; Kutkuhn B; Rösen P; Grabensee B Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522 [TBL] [Abstract][Full Text] [Related]
7. [Significance of insulin resistance to the pathogenesis of diabetes mellitus type II]. Ratzmann KP Pol Tyg Lek; 1989 May 22-29; 44(21-22):507-8. PubMed ID: 2702342 [No Abstract] [Full Text] [Related]
8. [Insulin resistance and cardiovascular complications]. Janka HU Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894 [TBL] [Abstract][Full Text] [Related]
9. [Insulin resistance]. Waldhäusl W Acta Med Austriaca; 1992; 19(4):96-100. PubMed ID: 1290322 [TBL] [Abstract][Full Text] [Related]
10. [Evolution of the concept of insulin resistance in the BigPRO studies. The BigPRO Group. Biguanides and Prevention of the Risk of Obesity]. Isnard F Journ Annu Diabetol Hotel Dieu; 1998; ():321-37. PubMed ID: 9773630 [No Abstract] [Full Text] [Related]
11. Exercise and insulin resistance in youth. Shaibi GQ; Roberts CK; Goran MI Exerc Sport Sci Rev; 2008 Jan; 36(1):5-11. PubMed ID: 18156947 [TBL] [Abstract][Full Text] [Related]
12. [Insulin resistance--possible causes and effects]. Bornkessel B Med Monatsschr Pharm; 1996 Mar; 19(3):81-4. PubMed ID: 8868967 [No Abstract] [Full Text] [Related]
13. [Insulin resistance and arterial hypertension]. Weidmann P; Müller-Wieland D; de Courten M; Krone W Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473 [TBL] [Abstract][Full Text] [Related]
14. [Resistance to insulin--pathomechanism, clinical syndromes]. Klin MJ; Madej A Pol Tyg Lek; 1996 Jan; 51(1-5):3-6. PubMed ID: 8754289 [No Abstract] [Full Text] [Related]
15. Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis. Mahdi GS Diabet Med; 1996 Apr; 13(4):389-90. PubMed ID: 9162617 [No Abstract] [Full Text] [Related]
16. [Pathophysiologic basis for obesity in diabetes type II]. Czech A; Bernas M; Tatoń J Pol Tyg Lek; 1995; Suppl 1():37-40. PubMed ID: 7596907 [No Abstract] [Full Text] [Related]
17. [Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Berges K; Ritz E Dtsch Med Wochenschr; 1995 Feb; 120(7):225-6. PubMed ID: 7859647 [No Abstract] [Full Text] [Related]
18. The insulin resistance syndrome. Smolar EN Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914 [No Abstract] [Full Text] [Related]
19. Insulin resistance: from benign to type 2 diabetes mellitus. Goldstein BJ Rev Cardiovasc Med; 2003; 4 Suppl 6():S3-10. PubMed ID: 14668698 [TBL] [Abstract][Full Text] [Related]
20. The deadly quartet--the insulin resistance syndrome. Opara JU; Levine JH South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]